As increased CRP levels in patients with stable COPD are associated with poor outcomes, including the occurrence of cardiovascular and thrombotic events, CRP assessment should be taken into consideration when COPD is newly diagnosed [55,56]. This evidence concerns the gene CRP and chronic obstructive pulmonary disease.